| scholarly article | Q13442814 |
| P356 | DOI | 10.3324/HAEMATOL.10869 |
| P698 | PubMed publication ID | 17550846 |
| P2093 | author name string | Ulrike Bacher | |
| Claudia Haferlach | |||
| Susanne Schnittger | |||
| Torsten Haferlach | |||
| Wolfgang Kern | |||
| P433 | issue | 6 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| myelodysplastic syndrome | Q954625 | ||
| P304 | page(s) | 744-752 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia | |
| P478 | volume | 92 |
| Q36109515 | Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML. |
| Q54392727 | Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms. |
| Q35872658 | Clonal architecture of secondary acute myeloid leukemia |
| Q36274109 | Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. |
| Q36770211 | Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes |
| Q50900611 | Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. |
| Q84615573 | FLT3 Mutations at Diagnosis and Relapse in Acute Myeloid Leukemia: Cytogenetic and Pathologic Correlations, Including Cuplike Blast Morphology |
| Q33856839 | FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia |
| Q85049016 | Genetic alterations in children and adolescents with acute myeloid leukaemia |
| Q35039992 | Genetic pathways leading to therapy-related myeloid neoplasms |
| Q37058777 | Genetics of therapy-related myelodysplasia and acute myeloid leukemia |
| Q35717828 | Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients |
| Q27851565 | IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. |
| Q39824884 | Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes |
| Q38127417 | Inherited predisposition to myeloproliferative neoplasms |
| Q36843787 | Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. |
| Q42573850 | MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition |
| Q37202615 | Minimal residual disease diagnostics in myeloid malignancies in the post transplant period |
| Q26749870 | Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy |
| Q36445968 | Molecular pathophysiology of myelodysplastic syndromes. |
| Q79757481 | Mutational analysis of SOS1 gene in acute myeloid leukemia |
| Q64959928 | Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. |
| Q47157448 | Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity |
| Q43014298 | NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All |
| Q37412298 | New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia |
| Q27016511 | New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice |
| Q92485655 | Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports |
| Q33871210 | Prognostic impact of RAS mutations in patients with myelodysplastic syndrome |
| Q37810120 | Prognostic molecular markers in myelodysplastic syndromes |
| Q45332140 | Prospective nested case-control study of feature genes related to leukemic evolution of myelodysplastic syndrome |
| Q38118553 | RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes |
| Q39682984 | Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome. |
| Q26859843 | Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q36591394 | Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia |
| Q37840934 | Standards and impact of hematopathology in myelodysplastic syndromes (MDS). |
| Q38171230 | Stem cell origin of myelodysplastic syndromes |
| Q36352506 | Targeting oncogenic Ras signaling in hematologic malignancies |
| Q64085749 | The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies |
| Q37671778 | The challenge of risk stratification in acute myeloid leukemia with normal karyotype |
| Q33829778 | The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure |
| Q24675681 | The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers |
| Q51815750 | The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes. |
| Q35103708 | The molecular basis of myeloid malignancies |
| Q36154674 | The serum tryptase test: an emerging robust biomarker in clinical hematology. |
| Q37621638 | Therapy-related myelodysplastic syndrome: models and genetics |
| Q35717790 | Therapy-related myeloid neoplasms following treatment with radioiodine |
| Q38611096 | Therapy-related myeloid neoplasms: when genetics and environment collide |
| Q36893706 | Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell |
| Q37671806 | Unraveling the molecular pathophysiology of myelodysplastic syndromes |
Search more.